Image not available

Bahílo Mateu P et al, 2017: Is extracorporeal shock wave lithotripsy a current treatment for urolithiasis? A systematic review.

Bahílo Mateu P, Budía Alba A, Liatsikos E, Trassierra Villa M, López-Acón JD, de Guzmán Ordaz D, Boronat Tormo F.
Servicio de Urología, Hospital Universitario y Politécnico La Fe, Valencia, España.
Universidad de Patras, Patras, Grecia.

Abstract

INTRODUCTION: Technological advances have prompted a change in the management of urolithiasis. Endourological techniques are gaining importance because they are highly effective treatments. The aim of this study was to answer the question of whether extracorporeal shock wave lithotripsy (ESWL) is still a competitive alternative compared with other therapeutic modalities.
ACQUISITION OF EVIDENCE: We conducted a literature search of articles published in the past 5 years. We identified 12 randomized and comparative studies and assessed the methodology and results of the study variables. We performed a narrative synthesis of the included studies. To summarise the variables, we used the mean and standard deviation for continuous variables and absolute numbers and percentages for the qualitative variables.
ANALYSIS OF THE EVIDENCE: Of the studies reviewed, 7 evaluated the various treatments for nephrolithiasis and 5 evaluated the treatments for ureteral lithiasis. At the renal level, a stone-free rate of 33.33-91.5% at 3 months was reached with ESWL, while a rate of 90.4-100% was achieved with the other endourological techniques, without finding statistically significant differences in the studies. At the ureteral level, a stone-free rate of 73.5-82.2% at 3 months was reached with ESWL, while a rate of 79-94.1% was achieved with the other endourological techniques, without finding statistically significant differences in the studies.
CONCLUSION: There is a lack of homogeneity among the published studies. ESWL is a minimally invasive treatment that with an appropriate technique and patient selection achieves high effectiveness, thus maintaining an important role at this time.

Actas Urol Esp. 2017 Mar 20. pii: S0210-4806(17)30024-4. doi: 10.1016/j.acuro.2017.01.011. [Epub ahead of print] English, Spanish.

 

0
 

Comentarios 1

Peter Alken en Miércoles, 23 Agosto 2017 08:03

No free access via Karolinska Institute and Heidelberg University.

No free access via Karolinska Institute and Heidelberg University.
Invitado
Miércoles, 21 Noviembre 2018
STORZ MEDICAL AG
Lohstampfestrasse 8
8274 Tägerwilen
Switzerland
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05

www.storzmedical.com